Astellas secures option for Audax’s cancer drug DAX-044
In
Investing.comBy Investing.com10/27/2026, 11:36:35 PM
EXECUTIVE SUMMARY
Astellas secures option for Audax’s cancer drug DAX-044....
Key Takeaways
- Astellas secures option for Audax’s cancer drug DAX-044.
Read Complete Original Article
Published originally on Investing.com
Related News
finance8 minutes ago
Earnings call transcript: ASMPT posts record bookings in Q3 2026 on AI demand
Earnings call transcript: ASMPT posts record bookings in Q3 2026 on AI demand....
finance13 minutes ago
RBNZ holds rates at 2.75% in split vote, signals further hikes likely
RBNZ holds rates at 2.75% in split vote, signals further hikes likely....
finance13 minutes ago
Earnings call transcript: SK hynix posts record Q3 2026 results, shares jump after hours
Earnings call transcript: SK hynix posts record Q3 2026 results, shares jump after hours....
finance21 minutes ago
Ringgit opens higher against US$ for eight consecutive trading days
Ringgit opens higher against US$ for eight consecutive trading days The Star
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!